Three S. Korean Drugmakers to Produce Merck’s COVID-19 Pill

SEOUL, Jan. 20 (Korea Bizwire) — Three South Korean companies are among 27 drugmakers chosen to produce low-cost versions of Merck & Co.’s COVID-19 pill for low- and-middle-income countries, the Medicines Patent Pool (MPP) and Seoul’s health ministry said Thursday. The U.N.-backed public health organization announced that it signed sublicense agreements with 27 generic drug [...]